Racial Disparities in Primary Liver Cancer Death

Authors

  • Dongyi Jiao

DOI:

https://doi.org/10.61173/y6gbzx69

Keywords:

Primary liver cancer, racial disparities, toxic metal, hereditary hemochromatosis

Abstract

Primary liver cancer is one of the four leading causes of cancer death in humans, and the ethnic diversity and wide distribution of the affected population are very serious, so it is important to control the mortality rate of primary liver cancer patients worldwide. In order to control the global proportion of patients with liver cancer and reduce the mortality rate of primary liver cancer, it is necessary to identify the differences between ethnic groups and explore the impact of these differences on the prevalence of primary liver cancer. Diet and genes make Spain and blacks in Europe and the United States more susceptible to liver cancer, while the culture and lifestyle of Asia make people in Central Asia and Southeast Asia more susceptible to hepatitis virus infection and non-alcoholic hepatitis (NAFLD). The specific activation temperature of Aspergillus flavus causes it to secrete aflatoxins in tropical and subtropical regions, and its exposure to the toxin can carry HBV infection and increase liver cancer’s prevalence in local residents. Gender is also a main factor of liver cancer’s mortality differences, which is mostly due to the fact that men have a higher proportion of smoking, alcohol abuse and overweight. This means that in countries with a high proportion of men, such as the U.A.E., Qatar, the Philippines and other Southeast Asian regions, the prevalence and mortality of liver cancer will be higher.

References

In 2020, there were about 900,000 liver cancer patients 1):4-13. worldwide, of which more than 800,000 died due to liver [6] Chuang SC, La Vecchia C, Boffetta P. Liver cancer: cancer. Primary liver cancer is one of the most common descriptive epidemiology and risk factors other than HBV and cause of cancer death in many countries, and East Asia HCV infection. Cancer Lett. 2009;286(1):9-14. has the highest mortality rates of liver cancer. Under the [7] Kardashian A, Serper M, Terrault N, Nephew LD. premise of controlling the mortality of liver cancer, schol- Health disparities in chronic liver disease. Hepatology. ars predict that the number of new cases and mortality 2023;77(4):1382-1403.

of liver cancer will increase by more than 50% by 2040. [8] Rumgay H, Arnold M, Ferlay J, et al. Global burden of

Therefore, in order to achieve a reduction in the burden primary liver cancer in 2020 and predictions to 2040. J Hepatol. of illness and medical stress, it is necessary to control the 2022;77(6):1598-1606. incidence rate by at least 3% per year. However, the prev- [9] Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. alence and mortality of liver cancer have not decreased Fraction and incidence of liver cancer attributable to hepatitis B significantly in recent decades, so the primary prevention and C viruses worldwide. Int J Cancer. 2018;142(12):2471-2477. Dean&Francis ISSN 2959-409X [10] Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Development. Gastroenterology. 2019;156(2):418-430. Estimations of worldwide prevalence of chronic hepatitis B virus [14] Tordrup D, Hutin Y, Stenberg K, et al. Additional resource infection: a systematic review of data published between 1965 needs for viral hepatitis elimination through universal health

and 2013. Lancet. 2015;386(10003):1546-1555. coverage: projections in 67 low-income and middle-income [11] Nayagam S, Thursz M, Sicuri E, et al. Requirements for countries, 2016-30. Lancet Glob Health. 2019;7(9):e1180-e1188. global elimination of hepatitis B: a modelling study. Lancet [15] Hino K, Yanatori I, Hara Y, Nishina S. Iron and liver cancer: Infect Dis. 2016;16(12):1399-1408. an inseparable connection. FEBS J. 2022;289(24):7810-7829. [12] Yu S, Zi X, Zhu Q, et al. Accelerating Decreases in the [16] Paganoni R, Lechel A, Vujic Spasic M. Iron at the Interface Incidences of Hepatocellular Carcinoma at a Younger Age in of Hepatocellular Carcinoma. Int J Mol Sci. 2021;22(8):4097. Shanghai Are Associated With Hepatitis B Virus Vaccination Published 2021 Apr 15. [published correction appears in Front Oncol. 2022 Sep [17] Yue T, Xu M, Cai T, et al. Gender disparity and temporal 20;12:950499. doi: 10.3389/fonc.2022.950499]. Front Oncol. trend of liver cancer in China from 1990 to 2019 and predictions 2022;12:855945. Published 2022 Apr 4. in a 25-year period. Front Public Health. 2022;10:956712. [13] Bailey JR, Barnes E, Cox AL. Approaches, Published 2022 Aug 26. P r o g r e s s , a n d C h a l l e n g e s t o H e p a t i t i s C Va c c i n e

Downloads

Published

2024-12-31